This article analyzes the available evidence to address airborne, aerosol transmission of the SARS‐CoV‐2. We review and present three lines of evidence: case reports of transmission for asymptomatic individuals in association with studies that show that normal breathing and talking produce predominantly small droplets of the size that are subject to aerosol transport; limited empirical data that have recorded aerosolized SARS‐CoV‐2 particles that remain suspended in the air for hours and are subject to transport over distances including outside of rooms and intrabuilding, and the broader literature that further supports the importance of aerosol transmission of infectious diseases.
The weight of the available evidence warrants immediate attention to address the significance of aerosols and implications for public health protection.
SOURCE: Risk Analysis
EDITOR’S NOTE: the authors make recommendations at the end of this well-researched commentary, including: ‘If aerosols are confirmed as an important transmission pathway for SARS‐CoV‐2, further explore airborne concentrations and the role of dose to various parts of the respiratory tract in the progression and severity of the disease. This information may inform public policy and earlier treatment decisions.’